Autism Biotech Overview
- Founded
- 2012
- Status
- Out of Business
- Latest Deal Type
- Out of Business
Autism Biotech General Information
Description
Developer of a biochemical test designed to offer early diagnosis of autism. The company's test develops therapies and detects autism from a drop of blood, enabling doctors to treat medical needs of patients with a Autism.
Contact Information
Primary Industry
Biotechnology
Primary Office
- The Innovation Centre
- Northern Ireland Science Park, Queen's Island
- Belfas BT3 9DT
- Northern Ireland, United Kingdom
+44 028 0000 0000
Autism Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 31-Mar-2020 | 00000 | Completed | Out of Business | ||
| 2. Early Stage VC | 22-Dec-2014 | 00000 | 00000 | 00.00 | Completed | Startup |
| 1. Grant | Completed | Startup |
Autism Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |